Ausgabe 2/2018
Inhalt (24 Artikel)
Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
Toshiaki Saito, Tsutomu Tabata, Hitoshi Ikushima, Hiroyuki Yanai, Hironori Tashiro, Hitoshi Niikura, Takeo Minaguchi, Toshinari Muramatsu, Tsukasa Baba, Wataru Yamagami, Kazuya Ariyoshi, Kimio Ushijima, Mikio Mikami, Satoru Nagase, Masanori Kaneuchi, Nobuo Yaegashi, Yasuhiro Udagawa, Hidetaka Katabuchi
Histological transformation after acquired resistance to epidermal growth factor tyrosine kinase inhibitors
Yi Shao, Dian-Sheng Zhong
Esophageal squamous cell neoplasia is an independent negative prognostic factor for head and neck cancer patients
Yasuhiko Hamada, Toshiro Mizuno, Kyosuke Tanaka, Masaki Katsurahara, Noriyuki Horiki, Reiko Yamada, Hiroyuki Inoue, Yoshiyuki Takei, Naoyuki Katayama
Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma
Yiyuan Cao, Haibo Xu, Meiyan Liao, Yanjuan Qu, Liying Xu, Dongyong Zhu, Bicheng Wang, Sufang Tian
Monitoring the estimated glomerular filtration rate (eGFR) in patients with small-cell lung cancer during chemotherapy: equations based on serum creatinine or cystatin C?
Xue Tian, Xinxing Zhang, Min Yu, You Lu, Zhenyu Ding, Meijuan Huang, Feng Peng, Li Ren, Jin Wang, Yongsheng Wang, Yong Xu, Jiang Zhu, Lin Zhou, Xiaojuan Zhou, Min Deng, Xin Tang, Youling Gong
A survival analysis using physique-adjusted tumor size of non-small cell lung cancer
Naoki Ozeki, Takayuki Fukui, Koji Kawaguchi, Shota Nakamura, Shuhei Hakiri, Taketo Kato, Akihiro Hirakawa, Kohei Yokoi
First-line bolus 5-fluorouracil plus leucovorin for peritoneally disseminated gastric cancer with massive ascites or inadequate oral intake
Hiroki Hara, Shigenori Kadowaki, Masako Asayama, Akira Ooki, Toko Yamada, Takako Yoshii, Kensei Yamaguchi
MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression
Chiara Baratelli, Marco Tampellini, Massimo Di Maio, Azzurra Ottone, Maria Pia Brizzi, Laura Forti, Irene Alabiso, Cristina Sonetto, Oscar Alabiso, Giorgio Vittorio Scagliotti
Selecting patients for hyperthermia combined with preoperative chemoradiotherapy for locally advanced rectal cancer
Sang-Won Kim, Ji Woon Yea, Jae Hwang Kim, Mi Jin Gu, Min Kyu Kang
Repeat cytoreduction and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal carcinomatosis of appendiceal origin
Toshiyuki Kitai, Kenya Yamanaka
The detection of sentinel lymph nodes in laparoscopic surgery can eliminate systemic lymphadenectomy for patients with early stage endometrial cancer
Tomohito Tanaka, Yoshito Terai, Satoe Fujiwara, Yoshimichi Tanaka, Hiroshi Sasaki, Satoshi Tsunetoh, Kazuhiro Yamamoto, Takashi Yamada, Masahide Ohmichi
Radiotherapy for vaginal cancer: a multi-institutional survey study of the Japanese Radiation Oncology Study Group
Hitoshi Ikushima, Masaru Wakatsuki, Takuro Ariga, Yuko Kaneyasu, Sunao Tokumaru, Fumiaki Isohashi, Noriko Ii, Takashi Uno, Tatsuya Ohno, Kokichi Arisawa, Takafumi Toita
Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma
Huilun Yang, Haiyang Hu, Yanling Gou, Yuhong Hu, Hui Li, Hongwei Zhao, Beidi Wang, Peiling Li, Zongfeng Zhang
Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
Ibrahim Yalcin, Mehmet Mutlu Meydanli, Ahmet Taner Turan, Salih Taskin, Mustafa Erkan Sari, Tayfun Gungor, Ozgur Akbayir, Ali Ayhan
Significance of sarcopenia as a prognostic factor for metastatic urothelial carcinoma patients treated with systemic chemotherapy
Hideyuki Abe, Kohei Takei, Toshitaka Uematsu, Yuumi Tokura, Issei Suzuki, Kazumasa Sakamoto, Daisaku Nishihara, Yoshiyuki Yamaguchi, Tomoya Mizuno, Akinori Nukui, Minoru Kobayashi, Takao Kamai
Impact of a robotic surgical system on treatment choice for men with clinically organ-confined prostate cancer
Takashi Kobayashi, Kent Kanao, Motoo Araki, Naoki Terada, Yasuyuki Kobayashi, Atsuro Sawada, Takahiro Inoue, Shin Ebara, Toyohiko Watanabe, Tomomi Kamba, Makoto Sumitomo, Yasutomo Nasu, Osamu Ogawa
Acute toxicity of image-guided hypofractionated proton therapy for localized prostate cancer
Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Mikiko Nakanishi, Toshiyuki Toshito, Yukihiro Umemoto, Shoichiro Iwatsuki, Yuta Shibamoto, Jun-etsu Mizoe
Significance of prostate-specific antigen kinetics after three-dimensional conformal radiotherapy with androgen deprivation therapy in patients with localized prostate cancer
Wataru Fukuokaya, Sangji Kim, Takao Natsuyama, Kanako Matsuzaki, Homare Shiomi, Hiroki Kitoh, Nobuko Utsumi, Hiromasa Kurosaki, Masafumi Inoue, Koichiro Akakura
Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma
Hiroshi Kobayashi, Tomotake Okuma, Hiroyuki Oka, Toshihide Hirai, Takahiro Ohki, Masachika Ikegami, Ryoko Sawada, Yusuke Shinoda, Toru Akiyama, Kenji Sato, Satoshi Abe, Hirotaka Kawano, Takahiro Goto, Sakae Tanaka
Retrospective analysis of first-line treatment for follicular lymphoma based on outcomes and medical economics
Manaka Muneishi, Ayaka Nakamura, Katsumi Tachibana, Junko Suemitsu, Shinji Hasebe, Kazuto Takeuchi, Yoshihiro Yakushijin
A double-blind randomized phase II dose-finding study of olanzapine 10 mg or 5 mg for the prophylaxis of emesis induced by highly emetogenic cisplatin-based chemotherapy
Takako Yanai, Satoru Iwasa, Hironobu Hashimoto, Fumiyoshi Ohyanagi, Tomomi Takiguchi, Koji Takeda, Masahiko Nakao, Hiroshi Sakai, Toshiaki Nakayama, Koichi Minato, Takahiro Arai, Kenichi Suzuki, Yasuhiro Shimada, Kengo Nagashima, Hiroyuki Terakado, Noboru Yamamoto
Risk of fatigue in cancer patients receiving anti-EGFR monoclonal antibodies: results from a systematic review and meta-analysis of randomized controlled trial
Jianhong Zhu, Wenxia Zhao, Dan Liang, Guocheng Li, Kaifeng Qiu, Junyan Wu, Jianfang Li
Further augmentation of molecular responses with dasatinib therapy in chronic myeloid leukemia patients who gained major molecular response under imatinib
Ahmet Emre Eskazan
Correction to: S-1 and irinotecan plus bevacizumab as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: a multicenter phase II study in Japan (KSCC1102)
Yuji Miyamoto, Akihito Tsuji, Hiroaki Tanioka, Soichiro Maekawa, Hirofumi Kawanaka, Masaki Kitazono, Eiji Oki, Yasunori Emi, Hidetsugu Murakami, Yutaka Ogata, Hiroshi Saeki, Mototsugu Shimokawa, Shoji Natsugoe, Yoshito Akagi, Hideo Baba, Yoshihiko Maehara